Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination
Mikhail Steklov, Silvia Pandolfi, Maria Francesca Baietti, et al.
Science (2018) Vol. 362, Iss. 6419, pp. 1177-1182
Open Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

LZTR1 is a regulator of RAS ubiquitination and signaling
Johannes W. Bigenzahn, Giovanna M. Collu, Felix Kartnig, et al.
Science (2018) Vol. 362, Iss. 6419, pp. 1171-1177
Open Access | Times Cited: 193
RAS: Striking at the Core of the Oncogenic Circuitry
Ryan C. Gimple, Xiuxing Wang
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 147
The RASopathies: from pathogenetics to therapeutics
Katie E. Hebron, Edjay R. Hernandez, Marielle E. Yohe
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 117
Ubiquitomics: An Overview and Future
George Vere, Rachel Kealy, Benedikt M. Kessler, et al.
Biomolecules (2020) Vol. 10, Iss. 10, pp. 1453-1453
Open Access | Times Cited: 102
LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases
Taiki Abe, Ikumi Umeki, Shin‐ichiro Kanno, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 3, pp. 1023-1035
Open Access | Times Cited: 101
RIT1 oncoproteins escape LZTR1-mediated proteolysis
Pau Castel, Alice Cheng, Antonio Cuevas-Navarro, et al.
Science (2019) Vol. 363, Iss. 6432, pp. 1226-1230
Open Access | Times Cited: 96
Therapeutic targeting of RAS: New hope for drugging the “undruggable”
Imran Khan, J. Matthew Rhett, John P. O’Bryan
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2019) Vol. 1867, Iss. 2, pp. 118570-118570
Open Access | Times Cited: 90
Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition
Daichi Inoue, Jacob T. Polaski, Justin Taylor, et al.
Nature Genetics (2021) Vol. 53, Iss. 5, pp. 707-718
Open Access | Times Cited: 84
The role of E3 ubiquitin ligases in the development and progression of glioblastoma
Luke Humphreys, Paul Smith, Zhuoyao Chen, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 522-537
Open Access | Times Cited: 66
The molecular genetics of RASopathies: An update on novel disease genes and new disorders
Marco Tartaglia, Yoko Aoki, Bruce D. Gelb
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 425-439
Open Access | Times Cited: 43
Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis
Farshad Farshidfar, Kahn Rhrissorrakrai, Chaya Levovitz, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma
Jie Fang, Shivendra V. Singh, Changde Cheng, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
TRIB3–TRIM8 complex drives NAFLD progression by regulating HNF4α stability
Meng‐Chao Xiao, Nan Jiang, Lilin Chen, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 778-791
Closed Access | Times Cited: 15
Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling
Marialetizia Motta, Miray Fidan, Emanuele Bellacchio, et al.
Human Molecular Genetics (2018) Vol. 28, Iss. 6, pp. 1007-1022
Open Access | Times Cited: 82
Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups
Caoimhe Egan, Alina Nicolae, Justin Lack, et al.
Haematologica (2019) Vol. 105, Iss. 4, pp. 951-960
Open Access | Times Cited: 74
Intronic CRISPR Repair in a Preclinical Model of Noonan Syndrome–Associated Cardiomyopathy
Ulrich Hanses, Mandy Kleinsorge, Lennart Roos, et al.
Circulation (2020) Vol. 142, Iss. 11, pp. 1059-1076
Open Access | Times Cited: 66
Exquisitely Specific anti-KRAS Biodegraders Inform on the Cellular Prevalence of Nucleotide-Loaded States
Shuhui Lim, Regina Khoo, Yu‐Chi Juang, et al.
ACS Central Science (2020) Vol. 7, Iss. 2, pp. 274-291
Open Access | Times Cited: 66
Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome
Yline Capri, Elisabetta Flex, Oliver H.F. Krumbach, et al.
The American Journal of Human Genetics (2019) Vol. 104, Iss. 6, pp. 1223-1232
Open Access | Times Cited: 64
Post-translational modification of RAS proteins
Sharon L. Campbell, Mark R. Philips
Current Opinion in Structural Biology (2021) Vol. 71, pp. 180-192
Open Access | Times Cited: 51
Ubiquitin ligases in cancer: Functions and clinical potentials
Shanshan Duan, Michele Pagano
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 918-933
Open Access | Times Cited: 50
The Ins and Outs of RAS Effector Complexes
Christina Kiel, David Matallanas, Walter Kölch
Biomolecules (2021) Vol. 11, Iss. 2, pp. 236-236
Open Access | Times Cited: 49
Risk of meningomyelocele mediated by the common 22q11.2 deletion
Keng Ioi Vong, Sangmoon Lee, Kit Sing Au, et al.
Science (2024) Vol. 384, Iss. 6695, pp. 584-590
Closed Access | Times Cited: 6
Heat Shock Protein 90 Interactome-Mediated Proteolysis Targeting Chimera (HIM-PROTAC) Degrading Glutathione Peroxidase 4 to Trigger Ferroptosis
Jinyun Dong, Furong Ma, Mao-Hua Cai, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16712-16736
Closed Access | Times Cited: 6
Precision medicine review: rare driver mutations and their biophysical classification
Ruth Nussinov, Hyunbum Jang, Chung‐Jung Tsai, et al.
Biophysical Reviews (2019) Vol. 11, Iss. 1, pp. 5-19
Open Access | Times Cited: 53
Delineation of dominant and recessive forms of LZTR1‐associated Noonan syndrome
Alistair T. Pagnamenta, Pamela J. Kaisaki, Fenella Bennett, et al.
Clinical Genetics (2019) Vol. 95, Iss. 6, pp. 693-703
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top